Cancer Immunotherapy Meets Oncology

In Honor of Christoph Huber

  • Cedrik Michael Britten
  • Sebastian Kreiter
  • Mustafa Diken
  • Hans-Georg Rammensee

Table of contents

  1. Front Matter
    Pages i-ix
  2. Immunological and Regulatory Framework for Immuno-oncology

    1. Front Matter
      Pages 1-1
    2. Marit M. van Buuren, Pia Kvistborg, Ton N. M. Schumacher
      Pages 13-20
    3. Tobias Bopp, Hans Christian Probst, Markus Radsak, Edgar Schmitt, Michael Stassen, Hansjörg Schild et al.
      Pages 21-27
    4. Cedrik Michael Britten, Thomas Hinz, Harpreet Singh-Jasuja, Ulrich Kalinke
      Pages 29-36
    5. Sjoerd H. van der Burg, Steffen Walter, Sylvia Janetzki, Cedrik Michael Britten, Jérôme Galon, Marij J. P. Welters et al.
      Pages 37-51
  3. Immunotherapies

    1. Front Matter
      Pages 63-63
    2. Cornelis J. M. Melief
      Pages 65-68
    3. H. Westdorp, K. F. Bol, M. Coşkuntürk, G. Schreibelt, I. J. M. de Vries, C. G. Figdor
      Pages 69-87
    4. S. Kreiter, M. Diken, U. Sahin
      Pages 89-100
    5. Martin Glennie, Özlem Türeci, Peter W. M. Johnson
      Pages 101-110
    6. Dolores J. Schendel, Philip D. Greenberg
      Pages 117-126
    7. Hinrich Abken, Winfried S. Wels, Klaus Kühlcke
      Pages 127-135
  4. Cancer Entities

About this book

Introduction

This book provides a comprehensive update on the state of the art in cancer immunology, which has rapidly evolved from a field of clinical research into an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and regulatory frameworks to the most promising therapeutic concepts. Themes include combination therapies and personalized medicine, as well as identification of biomarkers to guide the clinical development of new approaches and to pinpoint the optimal treatment for each patient. The book acknowledges the continuing dynamic nature of the field as reflected in the development of next-generation immunotherapies that are already in clinical testing.

 

Cancer Immunotherapy Meets Oncology is dedicated to the lifetime achievements of Christoph Huber, founder and chair of the Association for Cancer Immunotherapy (CIMT). It is also a tribute to those researchers and clinicians who are striving to develop novel diagnostics and tailored immunotherapies for the benefit of cancer patients.

Keywords

Biomarkers Cancer Immunotherapy Immuno-Oncology Novel Treatments

Editors and affiliations

  • Cedrik Michael Britten
    • 1
  • Sebastian Kreiter
    • 2
  • Mustafa Diken
    • 3
  • Hans-Georg Rammensee
    • 4
  1. 1.Immunotherapy Development Center (IDC)TRON-Translational Oncology University Medical Center, Johannes Gutenberg University MainzGermany
  2. 2.Department of Immunotherapy Development CenterTRON-Translational Oncology University Medical Center, Johannes Gutenberg-UniversityMainzGermany
  3. 3.Department of Immunotherapy Development CenterTRON-Translational Oncology University Medical Center, Johannes Gutenberg UniversityMainzGermany
  4. 4.Department of ImmunologyUniversity of TübingenTübingenGermany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-319-05104-8
  • Copyright Information Springer International Publishing Switzerland 2014
  • Publisher Name Springer, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-05103-1
  • Online ISBN 978-3-319-05104-8
  • About this book